Home
Conditions
Advanced Solid Tumor

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies

Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Completed

Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy

NCT05990920

Conditions: Advanced Cancer, Advanced Solid Tumor, Disease Attributes, +12 more
Locations: Angeles Clinic and Research Institute Los Angeles, California, United States

Sarcoma Oncology Center Santa Monica, California, United States

View Trial Details

Completed

A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

NCT04855929

Conditions: Adult Disease, Advanced Solid Tumor, Disease, +12 more
Locations: Hospital Vall d'Hebrón Barcelona, Spain

START Madrid, Hospital Universitario HM Sanchinarro Madrid, Spain

University Hospital Basel Basel, Switzerland

Cantonal Hospital St.Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

A Phase I Study of SCC244 in Patients with Advanced MET Alterations Solid Tumors

NCT03457532

Conditions: Advanced Solid Tumor
Locations: Shanghai East hospital Shanghai, China

View Trial Details

Completed

A Phase Ia/Ib Clinical Trial of IBI360 Monotherapy or in Combination With Sintilimab and (or) Chemotherapy in Advanced or Metastatic Solid Tumors

NCT05043298

Conditions: Advanced Solid Tumor
Locations: Innovent Biologics (suzhou) Co. , Ltd. Suzhou, Jiangsu, China

View Trial Details

Completed

Study to Evaluate the Safety and Anti-tumor Activity of SCC244

NCT03466268

Conditions: Advanced Solid Tumor
Locations: Guangdong General Hospital Guangzhou, China

View Trial Details

Completed

NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer

NCT04659629

Conditions: Advanced Solid Tumor, Neoplasms, Solid Tumor
Locations: Memorial Sloan Kettering Cancer Center New York, United States

Providence Cancer Center Oncology and Hematology Care Clinic Portland, Oregon, United States

UT- MD Anderson Houston, Texas, United States

Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Completed

A Study of KF-0210 in Advanced Solid Tumors Patients

NCT04713891

Conditions: Advanced Solid Tumor, Bladder Cancer, Carcinoma, +39 more
Locations: Scientia Clinical Research Limited Randwick, New South Wales, Australia

View Trial Details

Completed

JAB-3068 Activity in Adult Patients With Advanced Solid Tumors

NCT04721223

Conditions: Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, +24 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Completed

A Study of ZL-1211 in Patients With Advanced Solid Tumor

NCT05065710

Conditions: Advanced Solid Tumor
Locations: Zai Lab Site 2012 Scottsdale, Arizona, United States

Zai Lab Site 2016 Lynwood, California, United States

Zai Lab Site 2014 Indianapolis, Indiana, United States

Zai Site 2020 Hackensack, New Jersey, United States

View all 21 locations

View Trial Details

Completed

Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid Tumors

NCT05101109

Conditions: Advanced Solid Tumor
Locations: Seoul National University Bundang Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

Asan Medical Center Seoul, South Korea

Samsung Medical Center Seoul, South Korea

View Trial Details

Advanced Solid Tumor

Advanced Solid Tumor trial results

Related conditions